vikrant life sciences private limited.
Tender Performance & Track Record
Company Overview
Tender Performance
Data for 01 April 2024 to 17 June 2025
Total Bids / Contract Value
Qualified Bids / Q Rate
Total Wins / Win Value
Wins Rate / Q-W Rate
Detailed Performance Analysis
Tender Performance by Ministries
Name
Top Bid Competitors
Companies that frequently compete with you in the same tenders — ranked by their total win value.You applied for 48 bids — STERISAFE HEALTH SOLUTIONS appeared in 10 of them.
VIKRANT LIFE SCIENCES PRIVATE LIMITED.
VIKRANT LIFE SCIENCES PRIVATE LIMITED.
Financial Details
Registered Office
8-B 1, Big Jos Tower, Netaji Subhash Place, PitampuraNA-New Delhi-Delhi-110034-India
Industry Classification
Trading
Company Type
Market Information
Transform Your Tender Process
Join thousands of businesses winning more tenders
Smart Alerts
Get AI-powered tender recommendations
Market Intel
Track competitor bidding patterns
Email Reports
Weekly detailed analytics reports
Download Hub
Export tender data in bulk format
Smart Tracking
Never miss important deadlines
& Much More...
Discover all premium features with your trial
"TenderAI transformed our bidding process. We've increased our win rate by 40% and saved countless hours."
Historical Performance
7-year trend analysis (2018-2025)
Company Overview (1 Apr 2018-31 Mar 2025))
Total Bids
1,080
Contract Value
₹125.96 Cr
L1 Bids
116
Recent Win Rate
4.8%
Performance Analytics
VIKRANT LIFE SCIENCES PRIVATE LIMITED: Strategic Business Analysis - 116 L1 Wins
Executive Summary: This comprehensive business analysis report delves into the performance of Vikrant Life Sciences Private Limited, focusing on their strategic engagement in government tenders within the pharmaceutical sector. With a portfolio of 1078 tender participations and 116 L1 wins, Vikrant Life Sciences demonstrates significant potential. However, a recent win rate of 5.0% and an overall 'Concerning' financial health score of 40.8/100 indicate areas for improvement. This report provides a detailed assessment of their financial performance, competitive landscape, and strategic recommendations to enhance their market positioning and drive future growth in the pharmaceutical and healthcare sectors.
Financial Performance of Vikrant Life Sciences
This section analyzes the financial performance of Vikrant Life Sciences Private Limited, focusing on key metrics derived from their government tender activities. Understanding these metrics is crucial for assessing their financial health and identifying areas for improvement.
Key Financial Metrics
- Total Contract Value: Vikrant Life Sciences has secured contracts with a total value of ₹1,25,69,35,796.0, demonstrating their ability to win substantial government projects.
- Average Bid Amount: The average bid amount is ₹966,988.13, indicating the typical size of contracts they pursue.
- Earnest Money Deposit (EMD): An average EMD of ₹12,21,000.0 suggests their financial capability to participate in significant tenders.
- Win Rate: Overall win rate is 10.8% across all tenders, but a more recent rate of 5.0% signals a decline in success.
- Qualification Rate: The company achieves technical qualification in 65.4% of tenders, highlighting their compliance with technical requirements.